GSK plc (NYSE:GSK) is included among the 11 Best FTSE Dividend Stocks to Buy Right Now.
Image by Alexsander-777 from Pixabay
GSK plc (NYSE:GSK) is a major global healthcare company with operations in multiple therapeutic fields, including vaccines, respiratory, and oncology.
On October 27, Jefferies initiated coverage on GSK plc (NYSE:GSK) with a Buy rating and a price target of 2,000 GBp. The firm noted that, at a 30% discount, GSK “offers significant upside skew,” adding that the new CEO mainly needs to gain some time through an efficiency program, as there are early signs of progress in the company’s pipeline and potential for further business development, according to the analyst.
GSK plc (NYSE:GSK) recently posted its earnings for the third quarter of 2025. Total Q3 2025 sales reached £8.5 billion, marking a 5% increase from the same quarter last year. Its cash position remained solid, with cash generated from operations at £2.5 billion and free cash flow standing at £1.2 billion. This strong liquidity enabled the company to pay dividends of £1.9 billion to shareholders.
GSK plc (NYSE:GSK) is also a strong dividend payer, offering a dividend yield of 3.56% as of October 29.
READ NEXT: 10 Best Dividend Stocks Under $10 to Invest in and 10 Best Rising Dividend Stocks to Buy Now.
